aspartame
Enable an AI agent to recognise aspartame, assess the identity and condition of a specific material, and determine its suitability for a proposed sweetening use.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
Researched by: Codex + Grok
Purpose and description
Enable an AI agent to recognise aspartame, assess the identity and condition of a specific material, and determine its suitability for a proposed sweetening use.
Aspartame is the methyl ester of the dipeptide L-α-aspartyl-L-phenylalanine (C14H18N2O5), an intense non-nutritive sweetener authorised as food additive E 951 / INS 951 that is hydrolysed in the gut to aspartic acid, phenylalanine and methanol.
It can be Authenticate a sample and distinguish aspartame from related sweeteners or mixtures.; Calculate ingredient additions from measured aspartame content and formulation trials.; Evaluate dissolution and sweetness retention under a proposed process.; Assess stored material for loss of aspartame and changes in related substances.; Estimate use-specific intake and phenylalanine contribution from documented assumptions.; Recommend release, restricted use, further testing or rejection against an identified specification..
Distinguishing features
Confirm L-aspartyl-L-phenylalanine methyl ester identity using a suitable reference standard and analytical evidence; a sweet taste or trade name is insufficient. [FDA](https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food)
Require evidence resolving the intended peptide linkage and stereochemistry when related isomers could be present; molecular formula alone cannot establish identity.
Resolve aspartame from neotame, advantame and other sweeteners through a selective analytical method rather than inferring identity from their shared function.
Measure aspartame separately from carriers and co-sweeteners to distinguish the substance from a branded sweetener blend.
Distinguish intact aspartame from its degradation products before treating a stored material's original declared content as its present sweetening content.
Scope
+ Aspartame identity, including peptide linkage, methyl ester and stereochemistry
+ Aspartame content and relevant impurities in an identified material or mixture
+ Physical form, dissolution and handling characteristics
+ Sweetening performance and retention under specified formulation and storage conditions
+ Use-specific exposure, phenylalanine implications and applicable restrictions
- Complete food, beverage or tabletop sweetener formulations
- Other sweeteners, including neotame, advantame and acesulfame potassium
- Clinical diagnosis and management of phenylketonuria
- Manufacturing plant design and production equipment
- Independent substance models for degradation products and metabolites
Characteristics
- Identity confirmation
- unverified | supported | confirmed against stated method | conflicting Determines whether aspartame-specific conclusions can be applied to the material.
- Chemical and stereochemical identity
- Reference structure with peptide linkage, ester position and stereochemistry specified Separates aspartame from related compounds and isomers.
- Aspartame content
- % mass fraction or mg/g, with as-received or dry basis, method and uncertainty Supports dose calculation and distinguishes ingredient mass from active sweetener mass.
- Related substances profile
- mg/kg or % for individually identified analytes, with detection and quantification limits Supports assessment of purity and change during processing or storage.
- Material presentation
- powder | granules | solution | encapsulated preparation | blend; composition stated Changes sampling, dosing, dissolution and interpretation of assay results.
- Water content
- % mass fraction by stated method Supports assay-basis conversion and investigation of storage-related changes.
- Dissolution behaviour
- Solubility in g/L and dissolution time in seconds or minutes at stated temperature, pH and mixing conditions Determines whether the proposed process can distribute the intended dose.
- Relative sweetness
- Ratio to a stated sucrose reference under a specified sensory protocol and matrix Supports formulation decisions without treating sweetness as a universal conversion factor.
- Aspartame retention
- % of initial measured aspartame remaining after a stated exposure history Connects processing and storage to remaining functional ingredient.
- Phenylalanine contribution
- mg per serving or intended dose, with calculation basis and uncertainty Supports assessment of phenylalanine-related restrictions and communication.
- Applicable use authority
- Jurisdiction, authoritative instrument, version or effective date, product category and conditions Prevents approval in one context from being assumed to cover another.
- Use disposition
- unassessed | suitable under stated conditions | hold pending evidence | unsuitable for stated use Makes the resulting action conditional on a particular material and intended use.
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.aspartame
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 18 findings · 38 questions.
Aspartame identity Establish whether the material contains the intended aspartame substance and what the named material represents.
Sweetener names, shared chemistry and commercial preparations can obscure the substance actually being assessed.
Molecular recognition
Resolve chemical identity beyond a name or formula.
Structure and isomer confirmation
Record evidence for the intended peptide linkage, methyl ester and stereochemistry.
- What reference structure defines aspartame, including its peptide linkage and stereochemistry? definition
- Which analytical results distinguish the sample from relevant linkage or stereochemical isomers? measurement
- Which reference standard and method support the identification? provenance
Substance and preparation boundary
Distinguish aspartame from preparations containing it.
Ingredient versus blend
Record whether the assessed material is an aspartame ingredient, a solution or a multicomponent preparation.
- Does the supplied name identify aspartame itself or a preparation containing carriers and other sweeteners? boundary
- What measured fraction of the preparation is aspartame? measurement
- Which formulation or supplier record identifies the other components? provenance
Aspartame batch quality Establish the content and quality of the specific material proposed for use.
Nominal identity does not establish dose strength or conformity with a relevant ingredient specification.
Assay and basis
Make content results comparable and usable for dosing.
Interpretable aspartame assay
Connect measured content to its moisture basis, sampling context and analytical selectivity.
- What is the measured aspartame content, and is it reported on an as-received or dry basis? measurement
- Does the method resolve aspartame from co-sweeteners and relevant related substances in this material? measurement
- Which batch, sample date and sampling procedure do the results represent? provenance
Impurities and conformity
Compare relevant analytical evidence with an identified aspartame specification.
Related substances disposition
Record measured impurities, unresolved signals and the basis for accepting or holding the material.
- Which related substances and contaminants require assessment under the selected aspartame specification? definition
- What concentrations, quantification limits and unresolved analytical signals are reported? measurement
- Do the results support release for the intended use, or require further testing or rejection? action
Sweetening and incorporation Determine how the actual preparation supplies sweetness in the intended matrix.
Aspartame content alone cannot establish sensory equivalence or successful incorporation.
Matrix-specific sweetness
Relate dose to sensory performance under defined conditions.
Sweetness target and dose
Record evidence for the amount needed to achieve a specified sweetness profile.
- What aspartame concentration achieves the target sweetness against a stated reference in this matrix? measurement
- How do other sweeteners and ingredients affect sweetness intensity, onset or persistence? measurement
- What addition rate follows after accounting for the preparation's measured aspartame content? action
Dissolution and distribution
Determine whether the physical preparation can deliver a uniform dose.
Incorporation feasibility
Assess dissolution or distribution under the intended mixing and temperature conditions.
- How does the supplied particle form, carrier or encapsulation affect incorporation? boundary
- What dissolution time or distribution uniformity is measured under the intended process conditions? measurement
- What addition sequence and mixing conditions are supported by those results? action
Aspartame stability Track intact aspartame and its performance through processing and storage.
Aspartame can lose sweetness under heating, making exposure history relevant to suitability. [FDA](https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food)
Process exposure
Relate processing conditions to measured retention.
Process retention evidence
Record the conditions experienced by aspartame and evidence of their effects.
- What time-temperature profile, pH and aqueous exposure will aspartame experience? measurement
- What intact-aspartame retention and sweetness change have been measured after an equivalent process? measurement
- Does the evidence support the proposed addition stage or require a process change? action
Storage and degradation
Assess remaining quality from storage conditions and analytical change.
Remaining quality window
Distinguish measured stability from an unsupported extrapolation of a labelled shelf life.
- What storage duration, temperature, moisture exposure and packaging condition apply to this material? provenance
- How have intact aspartame and relevant degradation products changed relative to baseline? measurement
- What remaining use period or retesting decision is supported for these conditions? action
Aspartame use constraints Connect the intended use to exposure evidence, phenylalanine implications and applicable requirements.
People with phenylketonuria have particular restrictions concerning aspartame, and use decisions need an explicit population and regulatory context. [FDA](https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food)
Intake and phenylalanine
Represent exposure calculations without substituting them for individual clinical judgment.
Exposure and population boundary
Record intake assumptions and identify when phenylalanine restrictions require separate assessment.
- What aspartame intake in mg/kg body weight/day follows from stated serving, frequency, body-weight and other-source assumptions? measurement
- What phenylalanine contribution follows from the proposed dose, and what calculation basis supports it? measurement
- Does the intended population include people with phenylketonuria or another documented phenylalanine restriction? boundary
Authorization and communication
Resolve the conditions governing a specific use and the evidence supporting the decision.
Jurisdiction-specific use decision
Keep legal permission, exposure benchmarks and hazard assessments distinct when determining suitability.
- Which current authority governs aspartame in the intended jurisdiction and product category? provenance
- Which use limits, purity conditions and labelling requirements apply, and which cited assessments address hazard or exposure rather than legal permission? boundary
- Does the proposed use satisfy those conditions, and what evidence or communication remains necessary? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Kinds and varieties
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Food-grade crystalline or powder aspartame (assay-controlled additive)
- Tabletop sweetener formulations (e.g. Equal, Canderel, NutraSweet packets and tablets)
- Aspartame-acesulfame salt (E 962 / INS 962, a discrete salt, not a simple blend)
- Encapsulated or otherwise heat-protected aspartame for bakery and other thermal processes
- Beverage-application grades used in acidic carbonated and still drinks
- Pharmaceutical/excipient grades for chewable tablets, syrups and oral powders
- Particle-size grades (fine powder versus granular) sold for dry blending
- Which of these kinds and varieties hold for the sense of aspartame this model covers, and on what evidence? provenance
Identifiers and schemes
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- CAS Registry Number - 22839-47-0 - L-aspartyl-L-phenylalanine methyl ester
- EC number - 245-261-3 - EINECS/EC inventory
- E number / Codex INS - E 951 / INS 951 - Food-additive code; the related salt is E 962 / INS 962
- Wikidata - Q182040 - Item for aspartame
- FDA UNII - Z0H242BBR1 - Unique Ingredient Identifier
- PubChem CID - 134601 - Compound record for the L,L-methyl ester
- ChEBI - CHEBI:2877 - Chemical Entities of Biological Interest
- Which of these identifiers and schemes hold for the sense of aspartame this model covers, and on what evidence? provenance
Standards and regulation
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- US FDA: 21 CFR 172.804 (food additive regulation, including PKU labelling)
- European Union: Regulation (EC) No 1333/2008 (authorisation/conditions of use) and Regulation (EU) No 231/2012 (purity criteria for E 951)
- EU Food Information to Consumers: Regulation (EU) No 1169/2011 - 'contains a source of phenylalanine'
- JECFA: identity/purity specifications and ADI 0-40 mg/kg bw/day
- Codex Alimentarius: General Standard for Food Additives, INS 951
- EFSA: re-evaluation of E 951 (2013) and subsequent assessments, ADI 40 mg/kg bw/day
- IARC Monographs Volume 134 (2023): Group 2B, possibly carcinogenic to humans
- Food Chemicals Codex (FCC) monograph for aspartame
- Which of these standards and regulation hold for the sense of aspartame this model covers, and on what evidence? provenance
Real-world use
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Diet and 'zero' carbonated soft drinks and still beverages, where it supplies sweetness in an acidic matrix
- Tabletop packets, tablets and spoon-for-spoon blends in homes, cafés and food service
- Sugar-free chewing gum, mints and confectionery
- Low-sugar yogurts, desserts, drink mixes and breakfast cereals
- Oral pharmaceuticals (chewable tablets, reconstitutable powders, some syrups) as a palatability aid
- Which of these real-world use hold for the sense of aspartame this model covers, and on what evidence? provenance
Typical measurements
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Relative sweetness versus sucrose - 180-200 - dimensionless (sucrose = 1)
- Molar mass - 294.30 - g/mol
- Water solubility (about 20-25 °C) - about 10 - g/L
- Acceptable daily intake - 40 (JECFA/EFSA); 50 (US FDA) - mg/kg body weight per day
- pH of maximum aqueous stability - about 4.3 - pH
- Assay (food-additive specification) - typically ≥98.0 - % w/w
- Melting with decomposition - about 246-247 - °C
- Which of these typical measurements hold for the sense of aspartame this model covers, and on what evidence? provenance
Failure modes and hazards
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Hydrolysis in heat, high pH or prolonged storage, with loss of sweetness and formation of the diketopiperazine 5-benzyl-3,6-dioxo-2-piperazineacetic acid (DKP)
- Phenylalanine load is hazardous to people with phenylketonuria; labelling is mandatory in major markets
- Unsuitable for ordinary high-temperature baking unless encapsulated or otherwise protected
- Bitter or lingering off-taste at high use levels, often managed by blending with acesulfame K
- IARC Group 2B (2023) versus unchanged JECFA ADI creates conflicting public-health messaging without a change in permitted use
- Methanol is released on digestion; at authorised food uses the dose is not treated as a methanol-toxicity concern by JECFA/EFSA/FDA
- Which of these failure modes and hazards hold for the sense of aspartame this model covers, and on what evidence? provenance
Regional variation
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- ADI differs: 50 mg/kg bw/day in the United States versus 40 mg/kg bw/day at JECFA, EFSA and Codex
- EU/UK labels use E 951 and a phenylalanine source statement; US labels use the name aspartame plus 'PHENYLKETONURICS: CONTAINS PHENYLALANINE'
- Tabletop brand names differ: Equal/NutraSweet in the US, Canderel in much of Europe, other local marks in East Asia
- Japan lists it as a designated additive (アスパルテーム) under its own specification system
- The 2023 IARC 2B / JECFA split was communicated differently by national agencies, with most food regulators retaining existing authorisations
- Which of these regional variation hold for the sense of aspartame this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- Neotame (E 961) - N-(3,3-dimethylbutyl) analogue of aspartame; thousands of times sweeter, far less phenylalanine released. Separated by CAS 165450-17-9 versus 22839-47-0 and by INS 961 versus 951.
- Advantame (E 969) - Vanillin-derived N-substituted aspartame analogue (much higher potency). Separated by identity (E 969) and by distinct JECFA/FCC specifications.
- Acesulfame potassium (E 950) - Oxathiazinone dioxide salt, heat-stable, no phenylalanine. Separated by potassium content, lack of a PKU warning, and stability in baking.
- Sucralose (E 955) - Chlorinated sucrose, heat-stable, not a peptide. Separated by organochlorine identity and by remaining sweet after typical bake/retort.
- Aspartame-acesulfame salt (E 962) - A definite 2:1 molar salt, not a physical blend of E 951 and E 950; labelled as E 962 / INS 962 with its own specification.
- L-phenylalanine or L-aspartic acid - Free amino acids, not sweet at food-use levels and not methyl esters. Separated by CAS, by the absence of the methyl-ester function, and by lack of intense sweetness.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of aspartame this model covers, and on what evidence? provenance
Sources
- Aspartame and Other Sweeteners in Food - US authorisation history, FDA ADI of 50 mg/kg bw/day, permitted uses, and the mandatory phenylketonurics labelling statement.
- Aspartame hazard and risk assessment results released - IARC Group 2B classification (limited evidence of carcinogenicity) alongside JECFA's unchanged ADI of 0-40 mg/kg body weight per day.
- Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive - Identity, metabolism to aspartate, phenylalanine and methanol, purity/specification context, and EFSA's ADI of 40 mg/kg bw/day.
- 21 CFR 172.804 - Aspartame - US food-additive identity, conditions of use, and the required 'PHENYLKETONURICS: CONTAINS PHENYLALANINE' statement.
What the second pass must settle
- Which authoritative aspartame specification and validated analytical methods should govern identity, assay and impurity assessment for the intended grade?
- Which related substances, including possible diketopiperazine and hydrolysis products, require routine measurement in the actual process and storage context?
- What matrix-specific data establish sweetness, dissolution and aspartame retention over the intended processing and shelf-life conditions?
- Which current jurisdictional permissions, intake benchmarks and phenylalanine-related labelling requirements apply to the proposed use and population?
- Does an existing Vercy world model already own this substance concept, requiring this registry entry to link to that publication?